AbbVie
ABBV
HK$1,446
Share price
3.37%
Change (1 day)
10.06%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (ABBV) - Net assets
Net assets on the balance sheet as of December 2024 : HK$26.09 Billion
According to AbbVie's latest financial reports the company has HK$26.09 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
AbbVie - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $HK$26.11 B | -67.84% |
| 2023-12-31 | $HK$81.20 B | -39.88% |
| 2022-12-31 | $HK$135.06 B | 12.22% |
| 2021-12-31 | $HK$120.36 B | 18.55% |
| 2020-12-31 | $HK$101.53 B | -259.53% |
| 2019-12-31 | $-HK$63.65 Billion | -3.77% |
| 2018-12-31 | $-HK$66.14 Billion | -266.09% |
| 2017-12-31 | $HK$39.82 B | 10.77% |
| 2016-12-31 | $HK$35.95 B | 17.57% |
| 2015-12-31 | $HK$30.57 B | 126.3% |
| 2014-12-31 | $HK$13.51 B | -61.21% |
| 2013-12-31 | $HK$34.83 B | 33.63% |
| 2012-12-31 | $HK$26.06 B | -71.87% |
| 2011-12-31 | $HK$92.67 B | -24.16% |
| 2010-12-31 | $HK$122.20 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | HK$686.45 B | 2,530.71% | 🇺🇸 USA |
 | HK$127.11 B | 387.16% | 🇺🇸 USA |
 | HK$110.70 B | 324.24% | 🇺🇸 USA |
 | HK$45.58 B | 74.70% | 🇺🇸 USA |
 | HK$149.28 B | 472.12% | 🇺🇸 USA |
 | HK$129.66 B | 396.91% | 🇺🇸 USA |
 | HK$127.37 B | 388.16% | 🇬🇧 UK |
 | HK$317.02 B | 1,114.95% | 🇬🇧 UK |
 | HK$20.08 B | -23.02% | 🇺🇸 USA |